Preparation and Characterization of Transdermal Patches for the treatment of Arthritis

Millions of people worldwide suffer from arthritis, a common inflammatory disease that requires efficient and focused treatment approaches to reduce pain and enhance joint function. In order to treat arthritis locally, this study focuses on the creation and characterization of a Transdermal patch intended for the sustained release of anti-inflammatory drugs. To improve drug solubility and skin permeability, a combination of biocompatible polymers, such as Polyvinyl Pyrrolidine (PVP) and Hydroxypropyl methylcellulose (HPMC), were used in the formulation of transdermal patches. The patches' physical characteristics, such as their thickness, tensile strength, and moisture content, were assessed after they were loaded with Ibuprofen, a model anti-inflammatory medication. The results showed a pattern of controlled and sustained release. The Transdermal patches were applied to a rat model of Carrageenan /Kaolin induced arthritis for in vivo assessment. Clinical scoring of joint inflammation is used to evaluate the effectiveness of the treatment. In addition to a decrease in inflammatory markers ,the results showed that the treated group experienced a significant reduction in pain and swelling when compared to the control group. With benefits like increased patient compliance and fewer systemic side effects, this study shows that Transdermal patches have the potential to be a successful delivery method for the treatment of arthritis. In larger animal models and clinical trials, more research is required to optimize formulation parameters and examine the long-term safety and effectiveness of this novel therapeutic approach.